Results 71 to 80 of about 5,853 (155)

Sequence of Antibiotic Administration for the Treatment of Mycobacterium avium subsp. hominissuis Infection Might Influence the Response Outcome

Antibiotics
Background/Objectives: Mycobacterium avium subsp. hominissuis is a cause of disseminated infections in immunosuppressed patients and pulmonary infections in individuals with chronic lung conditions.
Amy Leestemaker-Palmer, Stephanie Nuss, Luiz E. Bermudez   +2 more
doaj   +1 more source

The efficacy and safety of a therapy regimen including raltegravir and a fixed dose combination of lamivudine and abacavir in previously rifabutin-treated patients with tuberculosis and HIV infection

Терапевтический архив, 2014
AIM. To evaluate the efficiency and safety of using raltegravir (RAL) twice daily in conjunction with a once-daily fixed dose combination of abacavir (ABC)/lamivudine (3TC) in patients with HIV infection and active tuberculosis who have not previously ...
A V Kravchenko, V N Zimina, A A Popova, M O Deulina, V G Kanestri, É S Ivanova, A A Iakovlev, V V Pokrovskiĭ   +7 more
doaj  

Newer Therapies for Refractory Helicobacter pylori Infection in Adults: A Systematic Review

Antibiotics
Background: Helicobacter pylori (H. pylori) infection is a global health concern, affecting approximately two-thirds of the world’s population. Standard first-line treatment regimens often fail, necessitating alternative rescue therapies.
Ligang Liu, Milap C. Nahata
doaj   +1 more source

Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn’s Disease

Antibiotics
This study, conducted between 4 October 2013, and 30 November 2018, tested the hypothesis that triple antimicrobial therapy, targeting Mycobacterium avium subspecies paratuberculosis (MAP), long considered a putative cause, would favorably affect Crohn’s
David Y. Graham, Saleh A. Naser, Thomas Borody, Zbigniew Hebzda, Harry Sarles, Scott Levenson, Robert Hardi, Tomasz Arłukowicz, Petar Svorcan, Reza Fathi, Aida Bibliowicz, Patricia Anderson, Patrick McLean, Clara Fehrmann, M. Scott Harris, Shuhong Zhao, Ira N. Kalfus   +16 more
doaj   +1 more source

The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy

Breast Cancer: Targets and Therapy, 2017
Richard E Kast,1 Nicolas Skuli,2 Samuel Cos,3 Georg Karpel-Massler,4 Yusuke Shiozawa,5 Ran Goshen,6 Marc-Eric Halatsch4 1IIAIGC Study Center, Burlington, VT, USA; 2INSERM, Centre de Recherches en Cancérologie de Toulouse – CRCT, UMR1037 ...
Kast RE, Skuli N, Cos S, Karpel-Massler G, Shiozawa Y, Goshen R, Halatsch ME   +6 more
doaj  

In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex

Microbiology Spectrum, 2021
Ka Lip Chew, Sophie Octavia, Siang Fei Yeoh, Jeanette W. P. Teo   +3 more
doaj   +1 more source

STAT6 Activation Exacerbates Ferroptosis in Airway Epithelium by Inhibiting PRKN‐Mediated Mitophagy in Pulmonary Fibrosis

Advanced Science
Pulmonary fibrosis (PF) remains a clinically intractable condition with limited therapies. Ferroptosis has emerged as a critical driver of PF. The previous study demonstrates that increased secretion of tissue plasminogen activator from ferroptotic ...
Youjing Yang, Guangbin Huang, Tao Zhang, Yi Ling, Junyu Jiang, Dingyuan Du, Yu Ma, Shasha Tao   +7 more
doaj   +1 more source

Rifabutin [PDF]

, 2020
openaire   +1 more source

Rifabutin boosts rifampicin accumulation in THP-1-derived M2 macrophages by inhibiting P-glycoprotein efflux activity. [PDF]

Arch Toxicol
Hamburg K, Bay C, Burhenne J, Weiss J, Stingl JC, Theile D.   +5 more
europepmc   +1 more source

Drug Exposure Dictates Evolutionary Dynamics of Drug-Resistant Tuberculosis: A Longitudinal Cohort Study in Beijing, China. [PDF]

Infect Drug Resist
Wen S, Li H, Shi Y, Wei R, Ge F, Pang Y, Liu Y.   +6 more
europepmc   +1 more source